Course Content (Syllabus)
The dual nature of medicines intended for human use as social goods, included in the protection of public health and at the same time as marketable goods determines their production and disposal. Both their production and their disposal are regulated, first of all, by a detailed interventionist legislative framework, such as the application of good practice rules and continuous control, with the aim of the absolute safety and effectiveness of the pharmaceutical products produced. At the same time, however, their inclusion in a profitable commercial environment requires the application of rules, which have been formulated in the context of a free market economy. The not always clear coexistence of the opposite goals is approached by this section, with analyzes of all production stages, as well as the ways of marketing drugs, that is, the operation of intermediate wholesalers, existing and electronic pharmacies, in Greece, the EU and also on a global level, with the presentation and interpretation of relevant legislation, such as Directive 2011/62/EU and Regulation 699/014, but also judicial decisions, mainly of the Court of Justice of the European Union, such as decisions C-322/01 Doc Morris , C-148/15 Deutsche Parkinson Vereinigung eV and others. It will also be special to deal with the function - profession of the pharmacist and its practice in Greece but also in other countries abroad, in the context of a comparative study of the relevant legislation, as well as the changes it has undergone over the years (presidential decree 340 /1993, article 64 of law 4509/2017).